Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Lumenis Ltd (NASDAQ: LMNS) acted responsibly on behalf of investors’ profitability in the planned $510 million sale to XIO Group.

On June 18, 2015, Lumenis Ltd (NASDAQ: LMNS) and XIO Group announced that they had entered into a merger agreement. Under the terms of the merger agreement, XIO Group will offer Lumenis shareholders $14.00 per share in cash for all outstanding shares.    

Based in Yokneam, Israel, and founded in 1991 Lumenis Ltd develops and markets energy-based medical systems used in minimally invasive procedures worldwide. It operates through three segments: Surgical, Ophthalmic, and Aesthetic. The company was formerly known as ESC Medical Systems Ltd. and changed its name to Lumenis Ltd in September 2001.

The investigation is looking to uncover whether Lumenis Ltd was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $18.00 per share.

If you purchased Lumenis Ltd (NASDAQ: LMNS) prior to June 18, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185